title: The search for safer glucocorticoid receptor ligands.
abstract: Steroidal glucocorticoids are commonly used due to their powerful antiinflammatory activity. However, despite their excellent efficacy, severe side effects frequently limit the use of these drugs. The search for novel glucocorticoids with reduced side effects has been intensified by the discovery of new molecular details regarding the function of the glucocorticoid receptor. These new insights may pave the way for novel, safer therapies that retain the efficacy of currently prescribed steroids.
authors.affiliation: Department of Molecular and Cell Biology, Ligand Pharmaceuticals, 10275 Science Center Drive, San Diego, California 92121, USA.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Rosen
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Miner
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001578:Benzopyrans / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008024:Ligands; D011804:Quinolines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011965:Receptors, Glucocorticoid / Q000378:metabolism*
chemical_list: C476829:10-methoxy-5-(2-propenyl)-2,5-dihydro-2,2,4-trimethyl-1H-(1)benzopyrano(3,4-f)quinoline; D000893:Anti-Inflammatory Agents; D001578:Benzopyrans; D005938:Glucocorticoids; D008024:Ligands; D011804:Quinolines; D011965:Receptors, Glucocorticoid